NCT01966029 - BMN 110 Phase 3B in Australian Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions

Mucopolysaccharidosis IVA (Morquio A Syndrome)

Interventions

DRUG

BMN 110

All pateints receive treatment with BMN 110

Trial Locations (5)

Children's Hospital at Westmead, Westmead

Murdoch Childrens Research Institute and Royal Children's Hospital, Melbourne

Princess Margaret Hospital for Children, Perth

Lady Cilento Children's Hospital (previous: Royal Children's Hospital), Brisbane

Pain and Anaesthesia Research Clinic, Royal Adelaide Hospital, Adelaide